Cambridge University spin-out Cambridge Bio-Augmentation Systems (CBAS), has partnered with Nvidia to bring AI-powered edge-computing to the most powerful communication network: the nervous system.
Bristol University spin-out Ziylo has been acquired by Danish pharmaceutical Novo Nordisk for over $800 million. Novo Nordisk now has full rights to Ziylo’s glucose binding molecule platform to develop glucose responsive insulins. The deal is one of th…